24/7 Patient Assistance: 760-405-8205

Alice Boylan, MD


Write a review
Doctor's profile photo

Request a call back

Conditions Treated Pleural Effusions Pleural Mesothelioma

specialties & services

  • Bio & Insurance Information

    Dr. Alice Boylan at the Hollings Cancer Center at the Medical University of South Carolina in Charleston has graduated in 1985 from the Temple University in Philadelphia. Her internal medicine residency was completed in 1988 at the Dartmouth-Hitchcock Medical Center followed by a fellowship in critical care and pulmonary disease in 1989 at the University of California in San Francisco. With three board certifications, in pulmonary disease, critical care and internal medicine, Dr. Boylan specializes in the treatment of very advanced and critical diseases, including mesothelioma. Dr. Alice Boylan’s focus on research has awarded her several grants in her specific research area. At least 20 of Dr. Boylan’s articles have been published in respected medical journals.

  • Education & Training


    Dickinson College, Carlisle, PA - 1979



    Temple University, Philadelphia, PA - 1985

    Medical School


    Dartmouth-Hitchcock Medical Center, Hanover, NH (1985-1988)



    University of California, San Francisco (1988-1992)


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Critical Care Medicine

    American Board of Internal Medicine - Pulmonary Disease

  • Hospital & Practice

    Hollings Cancer Center at the Medical University of South Carolina

    Languages: English/Spanish

    (843) 792-0700

    86 Jonathan Lucas St

    Charleston, South Carolina 29425

    Read More

    Ralph H. Johnson Veterans Affairs Medical Center

    Languages: English/Spanish

    (843) 577-5011

    109 Bee St

    Charleston, South Carolina 29401

    Read More
  • Publications & Memberships

    Dr. Alice Boylan has contributed to 4 publications.

    Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer.

    Boylan AM1, Wang XF, Ko R, Watson PM, Gu L, Harpole D, Bueno R, Kelly R, Kohman L, Kratzke R.

    See more >>

    CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes.

    Watson PM1, Miller SW, Fraig M, Cole DJ, Watson DK, Boylan AM.

    See more >>

    Common problems in critically ill obstetric patients, with an emphasis on pharmacotherapy.

    Ko R1, Mazur JE, Pastis NJ, Chang E, Sahn SA, Boylan AM.

    See more >>

    Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue.

    Johnson KR1, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, Harley RA, Obeid LM.

    See more >>


    American Thoracic Society

    International Mesothelioma Interest Group

    Society of Critical Care Medicine